The ALS Association has committed more than $55 million to find effective treatments and a cure for Lou Gehrig’s Disease. Our global research effort has helped increase the number of scientists working on ALS, advanced new discoveries and treatments, and has shed light on the complex genetic and environmental factors involved in ALS.  

The ALS Association has made significant research milestones in the fight against ALS, including:

• The groundbreaking discovery of the ALS gene, SOD1, responsible for 20 percent of all inherited ALS cases.
• Discovery of ALS6 in 2009, a new gene responsible for about 5% of all inherited ALS cases.
• The first clinical trial of ISIS-SOD1, a new drug that specifically targets the SOD1 gene.

Subscribe to our Research News with RSS

>> Genome Study Identifies Chromosome 9 Link to ALS 

>> Study Identifies New Genetic Risk Factor for Lou Gehrig’s Disease

>> Additional Information on New Study that Suggests a Potential Relationship Between Head Trauma and Motor Neuron Diseases 

>> ALS Association Announces New Research Grants 

>> Clinician-Scientist Development Award Applications due Oct. 1

See our Research News Archive 
for a full list of ALS research news items.